These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 1610830)

  • 1. Mechanism of inhibition of the class C beta-lactamase of Enterobacter cloacae P99 by phosphonate monoesters.
    Rahil J; Pratt RF
    Biochemistry; 1992 Jun; 31(25):5869-78. PubMed ID: 1610830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of inhibition of the class C beta-lactamase of Enterobacter cloacae P99 by cyclic acyl phosph(on)ates: rescue by return.
    Kaur K; Lan MJ; Pratt RF
    J Am Chem Soc; 2001 Oct; 123(43):10436-43. PubMed ID: 11673973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crystallographic structure of a phosphonate derivative of the Enterobacter cloacae P99 cephalosporinase: mechanistic interpretation of a beta-lactamase transition-state analog.
    Lobkovsky E; Billings EM; Moews PC; Rahil J; Pratt RF; Knox JR
    Biochemistry; 1994 Jun; 33(22):6762-72. PubMed ID: 8204611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-activity relationships in the inhibition of serine beta-lactamases by phosphonic acid derivatives.
    Rahil J; Pratt RF
    Biochem J; 1993 Dec; 296 ( Pt 2)(Pt 2):389-93. PubMed ID: 8257429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thermodynamic evaluation of a covalently bonded transition state analogue inhibitor: inhibition of beta-lactamases by phosphonates.
    Nagarajan R; Pratt RF
    Biochemistry; 2004 Aug; 43(30):9664-73. PubMed ID: 15274621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetics and mechanism of beta-lactamase inhibition by phosphonamidates: the quest for a proton.
    Rahil J; Pratt RF
    Biochemistry; 1993 Oct; 32(40):10763-72. PubMed ID: 8399224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphonate monoester inhibitors of class A beta-lactamases.
    Rahil J; Pratt RF
    Biochem J; 1991 May; 275 ( Pt 3)(Pt 3):793-5. PubMed ID: 1903928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inactivation of the Enterobacter cloacae P99 beta-lactamase by a fluorescent phosphonate: direct detection of ligand binding at the second site.
    Dryjanski M; Pratt RF
    Biochemistry; 1995 Mar; 34(11):3569-75. PubMed ID: 7893653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of reaction of acyl phosph(on)ates with the beta-lactamase of Enterobacter cloacae P99.
    Kaur K; Pratt RF
    Biochemistry; 2001 Apr; 40(15):4610-21. PubMed ID: 11294628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of covalently bound enzyme inhibitors as transition-state analogs by protein stability measurements: phosphonate monoester inhibitors of a beta-lactamase.
    Rahil J; Pratt RF
    Biochemistry; 1994 Jan; 33(1):116-25. PubMed ID: 8286328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetics and mechanism of inhibition of a serine beta-lactamase by O-aryloxycarbonyl hydroxamates.
    Pelto RB; Pratt RF
    Biochemistry; 2008 Nov; 47(46):12037-46. PubMed ID: 18942857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of beta-lactamases by monocyclic acyl phosph(on)ates.
    Kaur K; Adediran SA; Lan MJ; Pratt RF
    Biochemistry; 2003 Feb; 42(6):1529-36. PubMed ID: 12578365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of inhibition of the beta-lactamase of Enterobacter cloacae P99 by 1:1 complexes of vanadate with hydroxamic acids.
    Bell JH; Pratt RF
    Biochemistry; 2002 Apr; 41(13):4329-38. PubMed ID: 11914079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On the importance of a methyl group in beta-lactamase evolution: free energy profiles and molecular modeling.
    Bernstein NJ; Pratt RF
    Biochemistry; 1999 Aug; 38(32):10499-510. PubMed ID: 10441146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The D-methyl group in beta-lactamase evolution: evidence from the Y221G and GC1 mutants of the class C beta-lactamase of Enterobacter cloacae P99.
    Adediran SA; Zhang Z; Nukaga M; Palzkill T; Pratt RF
    Biochemistry; 2005 May; 44(20):7543-52. PubMed ID: 15895997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Lysine-Targeted Affinity Label for Serine-β-Lactamase Also Covalently Modifies New Delhi Metallo-β-lactamase-1 (NDM-1).
    Thomas PW; Cammarata M; Brodbelt JS; Monzingo AF; Pratt RF; Fast W
    Biochemistry; 2019 Jun; 58(25):2834-2843. PubMed ID: 31145588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetics of turnover of cefotaxime by the Enterobacter cloacae P99 and GCl beta-lactamases: two free enzyme forms of the P99 beta-lactamase detected by a combination of pre- and post-steady state kinetics.
    Kumar S; Adediran SA; Nukaga M; Pratt RF
    Biochemistry; 2004 Mar; 43(9):2664-72. PubMed ID: 14992604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphonamidate analogues of dipeptides with carboxypeptidase A and beta-lactamase-inhibitory activity: elucidation of the mechanism of beta-lactamase inhibition by electrospray mass spectrometry.
    Payne DJ; Bateson JH; Tolson D; Gasson B; Khushi T; Ledent P; Frère JM
    Biochem J; 1996 Mar; 314 ( Pt 2)(Pt 2):457-61. PubMed ID: 8670057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of serine amidohydrolases by complexes of vanadate with hydroxamic acids.
    Bell JH; Curley K; Pratt RF
    Biochem Biophys Res Commun; 2000 Aug; 274(3):732-5. PubMed ID: 10924345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metallic nanoparticles bioassay for Enterobacter cloacae P99 beta-lactamase activity and inhibitor screening.
    Liu R; Teo W; Tan S; Feng H; Padmanabhan P; Xing B
    Analyst; 2010 May; 135(5):1031-6. PubMed ID: 20419253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.